Indians will not have to wait until 2021 for corona antidote. This was made clear earlier by the Serum Institute, the world’s largest vaccine manufacturer responsible for its production.
But the agency did not say exactly when the vaccine would be available.
But reports from several news outlets in the country since Sunday (23rd August) morning claim that the COVID shield vaccine, developed by Oxford scientists, will hit the Indian market in just 73 days.
As the day progressed, so did the water of speculation. Finally, Adar Poonawalla, CEO of Serum Institute, opened his mouth about ’73 days’. He tweeted about it on Sunday afternoon.
The CEO of Serum Institute said that the claim that covid shield will be released in the Indian market within 73 days is untrue and misleading.
Ticker’s third phase trial is still ongoing. The decision to release this vaccine will be taken only after the trial is over.
In a recent interview, Adar Poonawalla, CEO of the Serum Institute, said that his company will produce about 400 million doses of covid shield in 2020.
He said 50 percent of the amount of antidote produced by his company would be allocated to the Indian market.
Apart from India, the vaccine will be delivered to 92 countries around the world.
According to an all-India newspaper, officials of the Serum Institute of India have said that the Government of India has given a special license to the Serum Institute.
This will make it possible to speed up the process of vaccine trial protocol.
It is expected that the test for this vaccine will be completed within 58 days the first dose of the third phase of the vaccine was given on Saturday, August 22 The second dose may be given 29 days after the first dose.
The report will be published 15 days after the second dose of the vaccine.
According to sources, the government will buy the covid shield vaccine directly from the Serum Institute and provide free vaccine to every Indian.
It is learned that by June 2021, the central government will buy 60 million corona vaccines from Serum Institute.
According to the Serum Institute, initially their primary goal was to produce 60 million corona vaccines per month.